GlassScriptPhysician profile
Hudman Hoo
NPI 1396730339
$51,406.01
in general payments reported to CMS, 2019-2025
51 companies · $1,460 in 2025
The $1,460 reported for 2025 was more than what 83% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,054 · 2020: $21K · 2021: $15K · 2022: $3,147 · 2023: $1,630 · 2024: $1,519 · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,447 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,447.02 |
| Education | $161.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $39,543.45 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $2,474.58 | 2019-2025 | |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,153.39 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $793.52 | 2019-2025 | Ofev, Jascayd |
| Insmed, INC. | $760.95 | 2019-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $681.43 | 2019-2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $325.26 | 2019-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $318.10 | 2019-2025 | |
| United Therapeutics Corporation | $306.23 | 2020-2025 | Tyvaso, Remodulin, Orenitram |
| Jazz Pharmaceuticals INC. | $290.48 | 2019-2023 | |
| Harmony Biosciences LLC | $268.04 | 2020-2024 | |
| Intuitive Surgical, INC. | $229.78 | 2022-2023 | Da Vinci Surgical System |
| Takeda Pharmaceuticals U.S.A., INC. | $229.68 | 2021-2025 | Glassia |
| Mylan Specialty L.P. | $216.49 | 2019-2023 | Yupelri |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $198.28 | 2022-2025 | Prolastin-C Liquid |
| Shionogi INC | $184.68 | 2020-2024 | Fetroja |
| Teva Pharmaceuticals USA, INC. | $174.40 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $167.09 | 2019-2020 | |
| Amgen INC. | $136.21 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $135.22 | 2023-2025 | Winrevair, Recarbrio, Dificid |
| Baxter Healthcare | $103.16 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Electromed, INC. | $96.50 | 2021-2024 | Smartvest |
| Portola Pharmaceuticals, LLC | $84.48 | 2019-2020 | |
| Fujifilm Healthcare Americas Corporation | $81.18 | 2023 | Fujifilm |
| Pfizer INC. | $64.90 | 2020-2024 | |
| Genentech USA, INC. | $64.32 | 2019-2022 | |
| Gilead Sciences, INC. | $59.99 | 2019-2023 | |
| Advanced Respiratory, INC | $55.22 | 2019-2021 | |
| Allergan, INC. | $54.61 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $50.21 | 2020-2024 | Xarelto |
| Viatris Specialty LLC | $46.15 | 2025 | Yupelri |
| Ambu INC. | $45.09 | 2020-2024 | |
| Philips North America LLC | $42.50 | 2019 | |
| Sandoz INC. | $38.94 | 2019 | |
| Abbvie INC. | $38.62 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $37.29 | 2019-2025 | |
| Melinta Therapeutics, LLC | $34.43 | 2019 | |
| Inogen, INC. | $31.78 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ani Pharmaceuticals, INC. | $31.78 | 2025 | Purified Cortrophin Gel |
| Inspire Medical Systems, INC. | $28.96 | 2024 | Inspire |
| Vapotherm INC | $28.69 | 2022 | |
| Pulmonx Corporation | $18.33 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Phadia US INC. | $16.72 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.36 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.25 | 2023 | Quviviq |
| Inari Medical, INC. | $13.08 | 2019 | |
| Nabriva Therapeutics, Plc | $12.94 | 2020 | |
| Boston Scientific Corporation | $11.27 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hudman Hoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.